Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31056598 | 1.00 | SLC6A2 (0.37) | SLC6A2SLC6A4PARP1FUCA1ALOX5 | |
| SCHEMBL31056540 | 0.86 | SLC6A2 (0.38) | SLC6A2SLC6A4PARP1FUCA1CTSL | |
| SCHEMBL29321033 | 0.86 | SLC6A2 (0.38) | SLC6A2SLC6A4PARP1FUCA1CTSL | |
| SCHEMBL29324068 | 0.83 | SLC6A2 (0.34) | SLC6A2SLC6A4PARP1FUCA1ALOX5 | |
| SCHEMBL31056959 | 0.83 | SLC6A2 (0.34) | SLC6A2SLC6A4PARP1FUCA1ALOX5 | |
| SCHEMBL29322206 | 0.79 | PARP1 (0.37) | SLC6A2SLC6A4PARP1FUCA1ALOX5 | |
| SCHEMBL29323710 | 0.76 | MAP4K1 (0.32) | SLC6A2SLC6A4 | |
| SCHEMBL31056780 | 0.76 | MAP4K1 (0.32) | SLC6A2SLC6A4 | |
| SCHEMBL29323701 | 0.76 | KDM4E (0.36) | SLC6A2SLC6A4ALOX5KMT2ACSNK2A1 | |
| SCHEMBL6965263 | 0.74 | KDM4E (0.43) | SLC6A2SLC6A4PARP1KMT2ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024148274-A1 | COMPLEMENT INHIBITION | APELLIS PHARMACEUTICALS, INC. (US) | 2024-07-11 | — | — | WO | disclosed |